Home > Portfolio
 
Companies under managements as of June 23, 2022.
Since 2020

Carbon Biosciences,
MA, USA

Catamaran Bio, Inc.,
Cambridge, MA, USA

DEM BioPharma, Inc.,
MA, USA

    

FUKUSHIMA SIC APPLIED ENGINEERING INC.
Fukushima, Japan

Mogrify Limited.,
Cambridge, UK

NeoPhore Limited., Inc.,
Cambridge, UK

       

Orna Therapeutics Holdings, LLC.,
MA, USA

PhoreMost Limited,
Cambridge, UK

Toregem BioPharma Co., Ltd.,
Kyoto, Japan

   

Turn Biotechnologies, Inc.,
Mountain View, CA

Stealth mode Company (Invested in 2022 Feb)

Before 2019

Twenty eight-Seven, Inc.
Cambridge, MA, USA

Bicycle Therapeutics Ltd.,
Cambridge, UK

Cleave Biosciences, Inc.,
Burlingame, CA, USA

CODA Biotherapeutics,
San Francisco, CA USA

Crescendo Biologics Ltd.,
Cambridge, UK

eFFECTOR Therapeutics, Inc.,
San Diego, CA, USA

     

Heartseed Inc.
Tokyo, Japan

Oncorus, Inc.Cambridge,
MA

Tizona Therapeutics, Inc.,
South San Francisco, CA

      

Trieza Therapeutics, Inc.,
Cambridge, MA

Trishula Terapeutics., South San Francisco,
CA

Tscan Therapeutics,
Cambridge, MA

Viamet Pharmaceuticals, Inc.,
Durham, NC, USA

F2G Ltd.,
Manchester, UK

PanOptica, Inc.
Bernardsville, NJ , USA



 
Copyright © 2005 - 2016 Astellas Venture Management. Site Map   Privacy Policy   Legal Disclaimer   Contact Us